摘要:
The invention relates to a salt or cocrystal of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol (component a) and at least one acid component (b1) or at least one acid component (b2), wherein the salt or cocrystal of component (a) and component (b2) is present in crystalline and/or amorphous form, a medicament comprising said salt or cocrystal as well as said salt or cocrystal for use in the treatment of pain.
摘要:
The invention relates to compounds of formula (I):
wherein R 1; R 2 , R 3 , R 4 , R 5 and
are as defined in the description. The compounds of formula (I) are inhibitors of the YAP/TAZ-TEAD interaction and thus useful in the treatment of cancer.
摘要:
The invention relates to compounds of formula I wherein R1, R2, R3, R4, R5 are as defined in the description. The compounds of formula I are useful for the treatment of diseases where inhibition of the YAP/TAZ-TEAD interaction is required.
摘要:
The invention relates to compounds of formula I
wherein R1, R2, R3, R4, R5 are as defined in the description. The compounds of formula I are useful for the treatment of diseases where inhibition of the YAP/TAZ-TEAD interaction is required.
摘要:
The present invention provides new stable crystalline N -iodoamides - 1-iodo-3,5,5-trimethylhydantoin (1-ITMH) and 3-iodo-4,4-dimethyl-2-oxazolidinone (IDMO). The present invention further provides a process for the preparation of organic iodides using N -iodoamides of this invention and recovery of the amide co-products from waste water.